164 related articles for article (PubMed ID: 18649116)
1. Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.
Vossen JA; Buijs M; Syed L; Kutiyanwala F; Kutiyanwala M; Geschwind JF; Vali M
Clin Exp Metastasis; 2008; 25(7):811-7. PubMed ID: 18649116
[TBL] [Abstract][Full Text] [Related]
2. [Effects of intra-arterial infusion of 3-bromopyruvate on metastases and survival benefit of hepatic VX2 tumor in rabbits].
Jiang XY; Zhang XP; Huang JH; Luo RG; Miao BJ; Wang Y
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(39):3139-42. PubMed ID: 24417996
[TBL] [Abstract][Full Text] [Related]
3. Hepatic intra-arterial injection of 3-bromopyruvate in rabbit VX2 tumor.
Shin SW; Han H; Choo SW; Yoo BC; Park CK; Do YS; Lee JH; Lee DH; Choi D; Choo IW; Kim SS; Lee JY
Acta Radiol; 2006 Dec; 47(10):1036-41. PubMed ID: 17135005
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
Xia X; Li X; Feng G; Zheng C; Liang H; Zhou G
Acta Radiol; 2013 Jul; 54(6):684-9. PubMed ID: 23507934
[TBL] [Abstract][Full Text] [Related]
5. Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study.
Vali M; Vossen JA; Buijs M; Engles JM; Liapi E; Ventura VP; Khwaja A; Acha-Ngwodo O; Ganapathy-Kanniappan S; Syed L; Wahl RL; Geschwind JF
J Pharmacol Exp Ther; 2008 Oct; 327(1):32-7. PubMed ID: 18591216
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
Deng G; Zhao DL; Li GC; Yu H; Teng GJ
Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
[TBL] [Abstract][Full Text] [Related]
7. Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.
Liapi E; Geschwind JF; Vali M; Khwaja AA; Prieto-Ventura V; Buijs M; Vossen JA; Ganapathy-Kanniappan S; Wahl RL
J Nucl Med; 2011 Feb; 52(2):225-30. PubMed ID: 21233194
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model.
Park HS; Chung JW; Jae HJ; Kim YI; Son KR; Lee MJ; Park JH; Kang WJ; Yoon JH; Chung H; Lee K
Korean J Radiol; 2007; 8(3):216-24. PubMed ID: 17554189
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and Histopathological Findings of Chemoembolization Using Cisplatin Powder Mixed with Degradable Starch Microspheres in a Rabbit Liver Tumor Model.
Sato T; Tanaka T; Nishiofuku H; Fukuoka Y; Sakaguchi H; Masada T; Tatsumoto S; Marugami N; Takano M; Yamato I; Sho M; Ohbayashi C; Hirai T; Kichikawa K
Cardiovasc Intervent Radiol; 2017 Mar; 40(3):438-444. PubMed ID: 27872985
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.
Parvinian A; Casadaban LC; Hauck ZZ; van Breemen RB; Gaba RC
Diagn Interv Radiol; 2015; 21(3):235-40. PubMed ID: 25835078
[TBL] [Abstract][Full Text] [Related]
11. The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.
Jae HJ; Chung JW; Park HS; Lee MJ; Lee KC; Kim HC; Yoon JH; Chung H; Park JH
Korean J Radiol; 2009; 10(6):596-603. PubMed ID: 19885316
[TBL] [Abstract][Full Text] [Related]
12. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer.
Vali M; Liapi E; Kowalski J; Hong K; Khwaja A; Torbenson MS; Georgiades C; Geschwind JF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):95-101. PubMed ID: 17296709
[TBL] [Abstract][Full Text] [Related]
13. Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization.
Li Z; Hu DY; Chu Q; Wu JH; Gao C; Zhang YQ; Huang YR
World J Gastroenterol; 2004 Jul; 10(13):1876-80. PubMed ID: 15222027
[TBL] [Abstract][Full Text] [Related]
14. Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model.
Chang JM; Chung JW; Jae HJ; Eh H; Son KR; Lee KC; Park JH
Acad Radiol; 2007 Jan; 14(1):85-92. PubMed ID: 17178370
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of gelatin sponge microparticles in a rabbit VX2 liver tumor model of hepatic arterial chemoembolization.
Zhang YW; Ao J; Liu Y; Qiao MX; Yang XL; Tang SX; Li C; Xu K
Tumour Biol; 2014 Nov; 35(11):10905-10. PubMed ID: 25085588
[TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of a monodisperse solid-in-oil-in-water miriplatin/ lipiodol emulsion in transcatheter arterial chemoembolization using a rabbit VX2 tumor model.
Yasui D; Yamane A; Itoh H; Kobayashi M; Kumita SI
PLoS One; 2020; 15(8):e0222553. PubMed ID: 32756561
[TBL] [Abstract][Full Text] [Related]
17. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
Geschwind JF; Ko YH; Torbenson MS; Magee C; Pedersen PL
Cancer Res; 2002 Jul; 62(14):3909-13. PubMed ID: 12124317
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of postoperative prophylactic transcatheter arterial chemoembolization (TACE) and transhepatic arterial infusion (TAI) after hepatectomy for primary liver cancer.
Chen J; Zhang Y; Cai H; Yang Y; Fei Duan Y
J BUON; 2018; 23(3):629-634. PubMed ID: 30003729
[TBL] [Abstract][Full Text] [Related]
19. Considerations for implantation site of VX2 carcinoma into rabbit liver.
Lee KH; Liapi E; Buijs M; Vossen J; Hong K; Georgiades C; Geschwind JF
J Vasc Interv Radiol; 2009 Jan; 20(1):113-7. PubMed ID: 19028118
[TBL] [Abstract][Full Text] [Related]
20. [Transcatheter arterial chemoembolization with high-dose iodized oil for hepatic VX2 tumor in rabbits].
Lü LS; Ma QY; Liu YM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2084-7. PubMed ID: 19861273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
